Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
+1 212 318 2000
Europe, Middle East, & Africa
+44 20 7330 7500
+65 6212 1000
SOUTH SAN FRANCISCO, Calif.
Rigel Pharmaceuticals Inc. said on Thursday that it has priced an offering of shares at $8 each, enough to raise about $130.4 million before expenses.
The company plans to sell 16.3 million shares in the offering, which will close June 1. All of the shares are being sold by Rigel, a development-stage drug company. Its underwriters can also buy another 2.4 million shares if there is enough demand.
Rigel shares rose 29 cents, or 3.4 percent, to $8.78 in afternoon trading.